Cargando…
Emerging Biomarkers for Screening and Management of Celiac Disease
Celiac disease (CeD) is a chronic, immune-mediated enteropathy that is precipitated by dietary gluten in genetically predisposed individuals expressing HLA-DQ2 and/or HLA-DQ8. In the current clinical practice, there are many serologic studies to aid in the diagnosis of CeD which include autoantibodi...
Autores principales: | Mir, Bilal Ahmad, Majeed, Tahir, Singh, Alka, Rajput, Mahendra Singh, Kumar, Asheesh, Chauhan, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167106/ https://www.ncbi.nlm.nih.gov/pubmed/35669726 http://dx.doi.org/10.1155/2022/2756242 |
Ejemplares similares
-
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
por: Agarwal, Ashish, et al.
Publicado: (2021) -
Impact of Corona Virus Disease 2019 pandemic on adherence to gluten-free diet in Indian patients with celiac disease
por: Mehtab, Wajiha, et al.
Publicado: (2021) -
Non-Invasive Biomarkers for Celiac Disease
por: Singh, Alka, et al.
Publicado: (2019) -
Emergence of Celiac Disease and Gluten-related Disorders in Asia
por: Mohta, Srikant, et al.
Publicado: (2021) -
Opportunities and challenges in the management of celiac disease in Asia
por: Agarwal, Ashish, et al.
Publicado: (2020)